TITLE OF PRESENTATION: Introduction to a co-design journey
DESCRIPTION: The objective of the talk is to introduce concepts of co-design and co-creation. How to define it and what are the particularities compared to other existing approaches. Then, we will discuss the key steps of a co-design process and its visible or collateral impacts. Finally, we will analyze how to start this type of process and the link with existing approaches in the world of health. Examples from various environments will be taken to inspire the audience.
Franck is a facilitator, coach and entrepreneur. With a technical background, he first managed innovative projects in large companies for fifteen years. Then, for more than ten years, he has been coaching around 300 startups, particularly in the problem-solution fit and user discovery phases. He started his activity first in Singapore, then in France and lately in Canada since 2019. In parallel, he manages since 2020 a startup in the sports world.In 2021, he wrote with André Fortin, the practical guide on co-creation. This guide is a synthesis of the co-creation approaches carried out in companies and universities over the previous six years. In 2023, Franck joins Espace-inc as a coach and lead coach for entrepreneurial approaches and continues to put into practice co-creation or co-design approaches within various ecosystems.
Catherine Wilhelmy, MBA
TITLE OF PRESENTATION: Thinking big: Toward cancer care systems where patient-provider co-design is front and centre.
DESCRIPTION: Patient partnership can be expressed on many levels in health care, from the individual level of being a valued member of the care team, to optimizing care with a medical establishment’s quality improvement department, all the way to policy-making involvement, medical training and research. At all these levels, co-designing with people with lived experience makes all the difference between patient centricity and true patient partnership. This talk will describe some concrete examples of successful co-designing initiatives between patients, health care professionals and researchers. The psychosocial impact on patient partners of codesign solutions in oncology will also be addressed.
Catherine became acquainted with cancer at the age of 10, as cancer took up residence within her mother, Grandmother, two aunts, close friends, spouse, and then in November 2018, he moved into her right breast. She was diagnosed with an aggressive triple negative crab grade 3, stage 3b. UNtil then. she was working as a consultant in a person-centered approach. Going through the mirror and becoming a patient herself, even if she was familiar with the concepts of partnership, she realized how little we know about patients' experiences. As she started chemo. the idea of a pilot project to improve the trajectory of cancer investigation became an intensive immersion to patient partnership. In research. The combination of her professional and firsthand experiences has revealed the immense potential that lies at the heart of a real partnership between the different actors in health care, and the meaningful impact of patient-provider-researcher-co-design. She believes that such collaboration leads to value creation through better care, costs, and satisfaction for all stakeholders. Today she see cancer as the story of a sad crab transformed into a wonderful opportunity to learn and pay forward.
TITLE OF PRESENTATION: Improving cancer care through co-design: an opportunity not to be wasted!
DESCRIPTION: This talk will discuss the process and value of engaging multiple stakeholders, including patients and families, in co-design of cancer system programs, services, and resources. Examples of co-design projects in psychosocial oncology will be provided to highlight key considerations, benefits, outcomes of bringing together different stakeholders to improve care and supports for people diagnosed with cancer.Dr. Robin Urquhart is an Associate Professor and the Canadian Cancer Society (Nova Scotia Division) Endowed Chair in Population Cancer Research in the Department of Community Health and Epidemiology, with cross-appointments in the Department of Surgery and Division of Medical Education, at Dalhousie University. She is a Senior Scientist with the Beatrice Hunter Cancer Research Institute and an Affiliate Scientist at Nova Scotia Health. Dr. Urquhart is also the Nova Scotia Lead of the Atlantic Cancer Consortium and Scientific Director of the Atlantic Partnership for Tomorrow’s Health (Atlantic PATH). Dr. Urquhart is a health services researcher and implementation scientist. Spanning the entire cancer continuum, from primary prevention to survivorship and end-of-life care, her research examines issues related to access, quality, equity, and effectiveness in cancer care and control, and investigates ways to improve care delivery and resultant patient, family, population, and health system outcomes